نتائج البحث

1

Combination immunotherapy using G-CSF and oncolytic virotherapy reduces tumor growth in osteosarcoma

المؤلفون: Stefano Gambera, Javier García-Castro, Angela Leo, Alvaro Morales-Molina

المساهمون: Asociación Pablo Ugarte contra el cáncer infantil, Asociación de Familias de Niños con Cáncer de Castilla-La Mancha, Instituto de Salud Carlos III, Comunidad de Madrid (España), Fundación Oncohematología Infantil, Asociación Pablo Ugarte, AFANION, Instituto de Salud Carlos III - ISCIII, Comunidad de Madrid, Fundación Oncohematología Infantil Asociación Pablo Ugarte

المصدر: Journal for Immunotherapy of Cancer
Repisalud
Instituto de Salud Carlos III (ISCIII)
Journal for ImmunoTherapy of Cancer, Vol 9, Iss 3 (2021)

مصطلحات موضوعية: lymphocytes, Cancer Research, medicine.medical_treatment, T-Lymphocytes, Immunomodulating Agents, Cytopathogenic Effect, Viral, Databases, Genetic, Granulocyte Colony-Stimulating Factor, Tumor Microenvironment, Immunology and Allergy, Lymphocytes, Oncolytic virotherapy, oncolytic virotherapy, RC254-282, Mice, Inbred BALB C, Osteosarcoma, Neoplasms. Tumors. Oncology. Including cancer and carcinogens, Combined Modality Therapy, Oncolytic Viruses, medicine.anatomical_structure, Oncology, Molecular Medicine, immunotherapy, Immunotherapy, T cell, Immunology, Bone Neoplasms, Mesenchymal Stem Cell Transplantation, programmed cell death 1 receptor, Adenoviridae, Immune system, Lymphocytes, Tumor-Infiltrating, Cell Line, Tumor, medicine, Animals, Humans, Virotherapy, t-lymphocytes, Pharmacology, business.industry, Mesenchymal stem cell, Programmed cell death 1 receptor, Mesenchymal Stem Cells, tumor-infiltrating, medicine.disease, Oncolytic virus, Oncolytic and Local Immunotherapy, Cancer cell, Cancer research, Tumor-infiltrating, business

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a8bb08e89d6a8c5e1630fcda8ad972e1Test
https://hdl.handle.net/20.500.12105/12645Test

2

Real-world insights on preferred treatments for steroid-refractory immune checkpoint inhibitor-induced pneumonitis

المؤلفون: Gatti-Mays, Margaret, Gulley, James L

المصدر: Journal for ImmunoTherapy of Cancer, Vol 9, Iss 2 (2021)
Journal for Immunotherapy of Cancer

مصطلحات موضوعية: 0301 basic medicine, Oncology, Cancer Research, medicine.medical_specialty, Immune checkpoint inhibitors, medicine.medical_treatment, Immunology, programmed cell death 1 receptor, 03 medical and health sciences, 0302 clinical medicine, Internal medicine, polycyclic compounds, medicine, Immunology and Allergy, Adverse effect, RC254-282, Pneumonitis, Pharmacology, business.industry, Incidence (epidemiology), Neoplasms. Tumors. Oncology. Including cancer and carcinogens, Immunotherapy, Programmed Cell Death 1 Receptor, medicine.disease, Clinical trial, Editorial, 030104 developmental biology, 030220 oncology & carcinogenesis, Molecular Medicine, immunotherapy, Steroid refractory, business, guidelines as topic, hormones, hormone substitutes, and hormone antagonists

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c649cef396578a61a9a2f9dc3a664994Test
https://jitc.bmj.com/content/9/2/e002252.fullTest

3

Hepatitis B virus reactivation in cancer patients with positive Hepatitis B surface antigen undergoing PD-1 inhibition

المؤلفون: Yuxiang Ma, Ming Zhao, Yan Huang, Xiuyu Cai, Wenqi Jiang, Yixin Zhou, Hongyun Zhao, Chen Chen, Xiaoshi Zhang, Wenfeng Fang, Zuan Lin, Shaodong Hong, Li Zhang, Xuanye Zhang, Rui-Hua Xu, Yunpeng Yang, Bei Zhang

المصدر: Journal for ImmunoTherapy of Cancer, Vol 7, Iss 1, Pp 1-10 (2019)
Journal for Immunotherapy of Cancer

مصطلحات موضوعية: Male, 0301 basic medicine, Cancer Research, HBsAg, medicine.medical_treatment, Programmed Cell Death 1 Receptor, medicine.disease_cause, Gastroenterology, B7-H1 Antigen, Antineoplastic Agents, Immunological, 0302 clinical medicine, Risk Factors, Neoplasms, PD-1, Immunology and Allergy, Cancer, biology, Checkpoint, virus diseases, Middle Aged, Reactivation, Hepatitis B, lcsh:Neoplasms. Tumors. Oncology. Including cancer and carcinogens, virology, Oncology, 030220 oncology & carcinogenesis, Molecular Medicine, Female, Immunotherapy, Safety, Antibody, liver disease, Research Article, Adult, PD-L1, medicine.medical_specialty, Hepatitis B virus, Immunology, Antiviral Agents, lcsh:RC254-282, Young Adult, 03 medical and health sciences, Internal medicine, Biomarkers, Tumor, medicine, Humans, Retrospective Studies, Pharmacology, Hepatitis, Chemotherapy, Hepatitis B Surface Antigens, business.industry, medicine.disease, digestive system diseases, 030104 developmental biology, Alanine transaminase, Commentary, biology.protein, Virus Activation, business

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3ea49583d5b5c254a92def2d9371d965Test
http://link.springer.com/article/10.1186/s40425-019-0808-5Test

4

Secondary resistance to immunotherapy associated with β-catenin pathway activation or PTEN loss in metastatic melanoma

المؤلفون: Stefani Spranger, Lauren L. Ritterhouse, Jonathan A. Trujillo, Jason J. Luke, Karen Matijevich, Jeremy P. Segal, Thomas F. Gajewski, Yuanyuan Zha

المصدر: Journal for ImmunoTherapy of Cancer, Vol 7, Iss 1, Pp 1-11 (2019)
Journal for Immunotherapy of Cancer

مصطلحات موضوعية: 0301 basic medicine, Male, Cancer Research, medicine.medical_treatment, Programmed Cell Death 1 Receptor, 0302 clinical medicine, Antineoplastic Agents, Immunological, PTEN-loss, Immunology and Allergy, β-Catenin activation, CTLA-4 Antigen, Melanoma, beta Catenin, Peptide vaccine, biology, High-Throughput Nucleotide Sequencing, Immune exclusion, Middle Aged, lcsh:Neoplasms. Tumors. Oncology. Including cancer and carcinogens, Interleukin-12, 3. Good health, medicine.anatomical_structure, Nivolumab, Oncology, 030220 oncology & carcinogenesis, Molecular Medicine, Immunotherapy, Antibody, Research Article, Signal Transduction, Adult, Metastatic melanoma, T cell, Immunology, Secondary resistance, Cancer Vaccines, lcsh:RC254-282, 03 medical and health sciences, Young Adult, medicine, PTEN, Humans, Pharmacology, business.industry, PTEN Phosphohydrolase, Ipilimumab, Blockade, 030104 developmental biology, Drug Resistance, Neoplasm, Catenin, biology.protein, Cancer research, Next-generation sequencing, business, Transcriptome, Immune checkpoint blockade

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c4b7cfeb16493056edddd6f47f459901Test
http://link.springer.com/article/10.1186/s40425-019-0780-0Test

5

Niclosamide, an antihelmintic drug, enhances efficacy of PD-1/PD-L1 immune checkpoint blockade in non-small cell lung cancer

المؤلفون: Fan Luo, Qi Xiang Rong, Min Luo, Hong Zhang, Zhen Chen, Hong Yun Zhao, Liwu Fu, Fang Wang

المصدر: Journal for ImmunoTherapy of Cancer, Vol 7, Iss 1, Pp 1-13 (2019)
Journal for Immunotherapy of Cancer

مصطلحات موضوعية: 0301 basic medicine, Cancer Research, Lung Neoplasms, medicine.medical_treatment, Programmed Cell Death 1 Receptor, Apoptosis, NSCLC, B7-H1 Antigen, STAT3, Mice, 0302 clinical medicine, Carcinoma, Non-Small-Cell Lung, Tumor Cells, Cultured, Immunology and Allergy, Niclosamide, biology, Antinematodal Agents, Antibodies, Monoclonal, lcsh:Neoplasms. Tumors. Oncology. Including cancer and carcinogens, medicine.anatomical_structure, Oncology, 030220 oncology & carcinogenesis, Molecular Medicine, Drug Therapy, Combination, Female, Immunotherapy, medicine.drug, Research Article, PD-L1, T cell, Immunology, lcsh:RC254-282, 03 medical and health sciences, medicine, Animals, Humans, Cell Proliferation, Pharmacology, business.industry, Drug Repositioning, Xenograft Model Antitumor Assays, Immune checkpoint, Blockade, Granzyme B, Mice, Inbred C57BL, 030104 developmental biology, Cancer cell, Cancer research, biology.protein, business

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::23b4656e47c8aed420fa4588eebad9c7Test
http://link.springer.com/article/10.1186/s40425-019-0733-7Test

6

Intratumoral injection of TLR9 agonist promotes an immunopermissive microenvironment transition and causes cooperative antitumor activity in combination with anti-PD1 in pancreatic cancer

المؤلفون: Carmine Carbone, Vincenzo Nasca, Paola Cappello, Maurizio Martini, Claudio Sette, Pietro Delfino, Francesco De Sanctis, Giampaolo Tortora, Vincenzo Corbo, Francesco Spallotta, Geny Piro, Aldo Scarpa, Stefano Ugel, Emilio Bria, Antonio Agostini

المصدر: Journal for ImmunoTherapy of Cancer, Vol 9, Iss 9 (2021)
Journal for ImmunoTherapy of Cancer 9 (2021). doi:10.1136/jitc-2021-002876
info:cnr-pdr/source/autori:Carbone C.; Piro G.; Agostini A.; Delfino P.; De Sanctis F.; Nasca V.; Spallotta F.; Sette C.; Martini M.; Ugel S.; Corbo V.; Cappello P.; Bria E.; Scarpa A.; Tortora G./titolo:Intratumoral injection of TLR9 agonist promotes an immunopermissive microenvironment transition and causes cooperative antitumor activity in combination with anti-PD1 in pancreatic cancer/doi:10.1136%2Fjitc-2021-002876/rivista:Journal for ImmunoTherapy of Cancer/anno:2021/pagina_da:/pagina_a:/intervallo_pagine:/volume:9
Journal for Immunotherapy of Cancer

مصطلحات موضوعية: Agonist, Cancer Research, medicine.drug_class, medicine.medical_treatment, Programmed Cell Death 1 Receptor, Immunology, [object Object], Adenocarcinoma, Injections, Intralesional, gastrointestinal neoplasms, Mice, Immune system, Pancreatic cancer, Animals, Humans, Immunology and Allergy, Medicine, tumor microenvironment, immunotherapy, RC254-282, Cell Proliferation, Clinical/Translational Cancer Immunotherapy, Settore BIO/16 - ANATOMIA UMANA, Pharmacology, Tumor microenvironment, business.industry, TLR9, Neoplasms. Tumors. Oncology. Including cancer and carcinogens, Immunotherapy, Acquired immune system, medicine.disease, Disease Models, Animal, Oncology, Toll-Like Receptor 9, Cancer cell, Cancer research, Molecular Medicine, business, Carcinoma, Pancreatic Ductal